vs
Side-by-side financial comparison of ASTRAZENECA PLC (AZN) and HSBC HOLDINGS PLC (HSBC). Click either name above to swap in a different company.
HSBC HOLDINGS PLC is the larger business by last-quarter revenue ($28.6B vs $14.5B, roughly 2.0× ASTRAZENECA PLC). HSBC HOLDINGS PLC runs the higher net margin — 25.7% vs 16.9%, a 8.7% gap on every dollar of revenue.
AstraZeneca plc (AZ) is a Swedish-British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
HSBC Holdings plc is a British universal bank and financial services group headquartered in London, England, with historical and business links to East Asia and a multinational footprint. It is the largest Europe-based bank by total assets, ahead of BNP Paribas, with US$3.098 trillion as of September 2024. This also puts it as the 7th largest bank in the world by total assets behind Bank of America, and the 3rd largest non-state owned bank in the world.
AZN vs HSBC — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $14.5B | $28.6B |
| Net Profit | $2.4B | $7.3B |
| Gross Margin | 82.9% | — |
| Operating Margin | 24.3% | 33.1% |
| Net Margin | 16.9% | 25.7% |
| Revenue YoY | 11.7% | — |
| Net Profit YoY | 27.0% | — |
| EPS (diluted) | $1.57 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | $14.5B | — | ||
| Q1 25 | — | $28.6B | ||
| Q2 24 | $12.9B | — | ||
| Q2 23 | $11.4B | — | ||
| Q2 22 | $10.8B | — |
| Q2 25 | $2.4B | — | ||
| Q1 25 | — | $7.3B | ||
| Q2 24 | $1.9B | — | ||
| Q2 23 | $1.8B | — | ||
| Q2 22 | $360.0M | — |
| Q2 25 | 82.9% | — | ||
| Q1 25 | — | — | ||
| Q2 24 | 83.1% | — | ||
| Q2 23 | 82.8% | — | ||
| Q2 22 | 72.2% | — |
| Q2 25 | 24.3% | — | ||
| Q1 25 | — | 33.1% | ||
| Q2 24 | 21.2% | — | ||
| Q2 23 | 21.5% | — | ||
| Q2 22 | 5.0% | — |
| Q2 25 | 16.9% | — | ||
| Q1 25 | — | 25.7% | ||
| Q2 24 | 14.9% | — | ||
| Q2 23 | 15.9% | — | ||
| Q2 22 | 3.3% | — |
| Q2 25 | $1.57 | — | ||
| Q1 25 | — | $0.36 | ||
| Q2 24 | $1.24 | — | ||
| Q2 23 | $1.17 | — | ||
| Q2 22 | $0.23 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.1B | $434.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $44.8B | $192.3B |
| Total Assets | $112.4B | $3017.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | $7.1B | — | ||
| Q1 25 | — | $434.9B | ||
| Q2 24 | $6.9B | — | ||
| Q2 23 | $5.7B | — | ||
| Q2 22 | $4.8B | — |
| Q2 25 | $44.8B | — | ||
| Q1 25 | — | $192.3B | ||
| Q2 24 | $39.6B | — | ||
| Q2 23 | $37.4B | — | ||
| Q2 22 | $36.0B | — |
| Q2 25 | $112.4B | — | ||
| Q1 25 | — | $3017.0B | ||
| Q2 24 | $104.3B | — | ||
| Q2 23 | $96.5B | — | ||
| Q2 22 | $96.6B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $65.3B |
| Free Cash FlowOCF − Capex | — | $64.0B |
| FCF MarginFCF / Revenue | — | 223.9% |
| Capex IntensityCapex / Revenue | — | 4.7% |
| Cash ConversionOCF / Net Profit | — | 8.90× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 25 | — | — | ||
| Q1 25 | — | $65.3B | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q2 25 | — | — | ||
| Q1 25 | — | $64.0B | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q2 25 | — | — | ||
| Q1 25 | — | 223.9% | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q2 25 | — | — | ||
| Q1 25 | — | 4.7% | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
| Q2 25 | — | — | ||
| Q1 25 | — | 8.90× | ||
| Q2 24 | — | — | ||
| Q2 23 | — | — | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
